CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	May 31, 2024	May 31, 2023
Operating Activities:
Net income	$ 109,807	$ 93,824
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	61,114	53,264
Allowance for doubtful accounts	(5)	(46)
Loss on sale of property and equipment	872	295
Deferred income taxes	461	(723)
Equity in losses (gains) of unconsolidated affiliates	(82)	63
Stock-based compensation	12,652	13,522
Change in operating assets and liabilities:
Receivables, prepaid expenses and other current assets, non-current assets, accrued salaries and benefits, deferred membership income and other accruals	(12,998)	(5,229)
Merchandise inventories	(45,057)	21,831
Accounts payable	38,990	7,880
Net cash provided by operating activities	165,754	184,681
Investing Activities:
Additions to property and equipment	(141,873)	(96,557)
Purchases of short-term investments	(134,108)	(123,317)
Proceeds from settlements of short-term investments	125,464	21,842
Proceeds from disposal of property and equipment	1,138	218
Net cash used in investing activities	(149,379)	(197,814)
Financing Activities:
Proceeds from long-term bank borrowings	16,500	38,712
Repayment of long-term bank borrowings	(21,433)	(31,407)
Proceeds from short-term bank borrowings	3,884	3,156
Repayment of short-term bank borrowings	(2,941)	(3,229)
Cash dividend payments	(48,437)	(14,290)
Purchase of treasury stock	(71,852)	(5,993)
Net cash used in financing activities	(124,279)	(13,051)
Effect of exchange rate changes on cash and cash equivalents and restricted cash	(3,956)	11,183
Net decrease in cash, cash equivalents	(111,860)	(15,001)
Cash, cash equivalents and restricted cash at beginning of period	252,202	251,373
Cash, cash equivalents and restricted cash at end of period	140,342	236,372
Supplemental disclosure of noncash investing activities:
Capital expenditures accrued, but not yet paid	3,514	4,052
Dividends declared but not yet paid	17,771	14,426
Reconciliation of cash, cash equivalents, and restricted cash:
Cash and cash equivalents	128,271	222,668
Short-term restricted cash	2,832	2,965
Long-term restricted cash	9,239	10,739
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows	$ 140,342	$ 236,372